Screening for liver cancer in people with cirrhosis

People with cirrhosis from HCV are at risk for liver cancer, even if they have been cured. 

Regular screening can detect early-stage liver cancer. 

This is usually an ultrasound, computed tomography (CT) or Magnetic Resonant Imaging (MRI) scan. It also includes a blood test for alpha-fetoprotein (AFP; a protein made in foetal liver tissue). 

Screening is usually every six months.

Last updated: 1 November 2024.